EP1713523B1 - Adhesive composition comprising hydrophilic and hydrophobic silicone elastomers - Google Patents

Adhesive composition comprising hydrophilic and hydrophobic silicone elastomers Download PDF

Info

Publication number
EP1713523B1
EP1713523B1 EP04762804.5A EP04762804A EP1713523B1 EP 1713523 B1 EP1713523 B1 EP 1713523B1 EP 04762804 A EP04762804 A EP 04762804A EP 1713523 B1 EP1713523 B1 EP 1713523B1
Authority
EP
European Patent Office
Prior art keywords
silicone
adhesive
hydrophilic
adhesive composition
hydrophobic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP04762804.5A
Other languages
German (de)
French (fr)
Other versions
EP1713523A2 (en
Inventor
Chaabane Bougherara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coloplast AS
Original Assignee
Coloplast AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coloplast AS filed Critical Coloplast AS
Publication of EP1713523A2 publication Critical patent/EP1713523A2/en
Application granted granted Critical
Publication of EP1713523B1 publication Critical patent/EP1713523B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/58Adhesives
    • A61L15/585Mixtures of macromolecular compounds

Definitions

  • the invention relates to an adhesive composition and a medical device comprising an adhesive composition.
  • Medical devices such as wound care devices and ostomy appliances may comprise adhesives for direct contact with the skin. It is important that the adhesive is skin-friendly, as the skin often is damaged or just extremely fragile, especially when handling chronic wounds. Different suitable adhesives are known in the art. Hydrocolloid adhesives are often used, due to their permeability and good absorption properties. Acrylic adhesives may also be used, especially for thin applications, as the permeability is low.
  • Silicone adhesives are very skin-friendly and very suitable for donating active agents, such as in medicated patches, but they are also rather occlusive and hydrophobic, which is a mayor disadvantage for a product being worn for prolonged period, such as wound dressings, ostomy appliances or incontinence devices.
  • WO 02/087642 discloses an adhesive comprising a hydrophilic phase and a hydrophobic phase.
  • the hydrophobic phase may be a silicone elastomer and the hydrophilic phase may be a water absorbing mixture of hydrophilic polymers of non-silicone origin.
  • WO 02/076519 a silicone-based moisture absorbing matrix for wound care products.
  • the sticky matrix comprises silicone, gelling agent and optionally a silicone resin. Both silicone compounds are hydrophobic and the reference is silent with respect to the use of hydrophilic silicone.
  • EP 0312 265 discloses adhesive compositions comprising blends of polyethylene oxide-grafted silicone polymers with resinous copolymers.
  • the adhesive compositions enhance release, in a controlled fashion, of bioactive or chemical agents blended or otherwise dispersed through the compositions.
  • the object of the present invention is to provide an adhesive composition, being skin-friendly and at the same time having good permeability properties.
  • Another object of the invention is to provide a silicone adhesive with absorption properties.
  • Yet another object of the invention is to provide a skin-friendly adhesive with a good cohesion to the skin and yet easy to remove.
  • Still another object of the invention is to provide a skin-friendly adhesive that reduces cell-stripping when removed from the skin.
  • Still another object of the invention is to provide an adhesive with good cohesion.
  • the invention relates to an adhesive composition
  • an adhesive composition comprising hydrophilic silicone elastomers and hydrophobic silicone elastomers and optionally water absorbent material, wherein the ratio between the hydrophilic silicone elastomers and the hydrophobic silicone elastomers is from 5:95 to 95:5.
  • the ratio between the hydrophilic silicone elastomers and the hydrophobic silicone elastomers may be from 10:90 to 90:10, preferably 20:80 to 80:20, more preferred 30:70 to 70:30 and most preferred 40:60 to 60:40.
  • the ratio between the hydrophilic silicone and the hydrophobic silicone is from 10:90 to 40:60, more preferably from 20:80 to 30:70.
  • the ratio between the hydrophilic silicone and the hydrophobic silicone is from 5:95 to 50:50. In another embodiment of the invention ratio between the hydrophilic silicone and the hydrophobic silicone is from 95:5 to 50:50.
  • the ratio may in one embodiment of the invention be 25:75.
  • the ratio between the hydrophilic silicone and the hydrophobic silicone is from 90:10 to 60:40, more preferably from 80:20 to 70:30.
  • the ratio is 75:25.
  • hydrophobic silicone and hydrophilic silicone By mixing hydrophobic silicone and hydrophilic silicone into an adhesive composition the interaction between the two groups of polymers are optimal, due to their related nature, compared to mixtures of hydrophobic silicone and other hydrophilic polymers than silicones.
  • Silicones such as trimethylsilyloxane terminated polydimetylsiloxane, are hydrophobic. These have an advantage of being inert to hydrophilic substances, which means that these substances are not dissolved in silicone and therefore are able to migrate out of the silicone. This explains why silicone is a good as drug release matrix.
  • silicone that is relatively less hydrophobic than trimethylsilyloxy-terminated polydimetylsiloxane but still can be used as a PSA (pressure sensitive adhesive) adhesive.
  • Hydrophobic silicones can be made hydrophilic by replacing some of the methyl groups along the chain or the chain ends with hydrophilic moieties well-known to those skilled in the art, such moieties may be oxymethylene and/or oxypropylene, acrylate amide, amines imines etc.
  • the hydrophilicity or hydrophobicity may also be adjusted to the desired value by radio frequency or electrical current phase plasma treatment or corona treatment of the silicone fluid stream that passes into a chamber where plasma or corona is generated., and that or these monomer moieties that renders hydrophobic silicone hydrophilic is/are introduced.
  • Hydrophilic silicones capable of absorbing small amounts of water are known.
  • An example may be Silicone 4000 series produced by DOW Corning.
  • the water absorption may be further increased by incorporating water-absorbing material such as CMC or cross-linked acrylates.
  • water-absorbing material such as CMC or cross-linked acrylates.
  • such silicone adhesive has low cohesiveness and is thus unsuitable in use for medical devices.
  • the cohesiveness of the silicone adhesive may be increased by combining hydrophobic and hydrophilic silicone.
  • the surface energy of the composition according to the present invention measured in terms of water-in-air contact angle for a fully cured silicone mixture against a glass plate, without the absorbing agent and other ingredients mentioned in examples below, is preferably between 65 and 105 degree, more preferred between 75 and 100 degree and most preferred between 80 and 95 degree.
  • the surface energy can be measured by the water-in-air contact angle method known in the art, where the angle between a drop of distilled water and the surface of the substrate is measured.
  • surface energy is also determined from the chemical structure of the silicone mixtures using the surface and interfacial tension of polymers, oligomers, plasticizers, and additives involved in the composition.
  • the cohesiveness of the adhesive of the present invention is important when the adhesive has to be removed from a skin or wound site. Low cohesiveness may result in adhesive residues left on the skin or wound site or in the areas surrounding the wound site, and/or trauma while removing the adhesive due to a high peel force.
  • the ratio that suits both water absorption and gel cohesiveness may also influence the peel force of the PSA to be achieved.
  • the actual peel span of silicone elastomers lies between over 70 N for a 100% hydrophilic elastomer to around 0,5 N for 100% hydrophobic elastomer.
  • the peel force of the adhesive of the present invention may be from 1 N to 20 N measured according to 180 degree method DS/EN/28510-2.
  • the peel force between 1 N and 10 N, more preferably the peel force is from 1 N to 5 N.
  • Peel force and gel cohesiveness can be influenced by varying the ratio between the hydrophilic and the hydrophobic silicone. Furthermore, the peel force may be further adjusted by incorporating some other ingredients such as kaolin, crystalline silica magnesium oxide, calcium carbonate or other reinforcing fillers, plasticisers, such as a low molecular silicone oil, e.g. hexamethylene disiloxane, soya bean oil or the derivative thereof, castor oil or the derivative thereof, or other additives known to persons skilled in the art.
  • plasticisers such as a low molecular silicone oil, e.g. hexamethylene disiloxane, soya bean oil or the derivative thereof, castor oil or the derivative thereof, or other additives known to persons skilled in the art.
  • additives may be UV stabilizers such as those known under trade name "Irganox, Cyanox, Hostanox", antioxidants, and cross-linking agents such as peroxides, divinylbenzene.
  • Other suitable compounds may be acrylic or vinyl ended silicone moieties having an average molecular weight ranging 100 to 10.000. These moieties are also referred to as cross-linking agents.
  • Adhesion promoters may also be added to the silicone mixtures in order to improve the affinity of the silicone adhesive for the substrate onto which the adhesive is to be applied.
  • the adhesion promoters may be silicone based, such as those commercialized by Dow Corning under the name "Silane Z-603". Titan based such those commercialized by Du Pont under the name “Tyzor AA 105" may also be used.
  • Adhesion promoters can be mixed into the silicone composition prior to coating and curing, or simply used as a primer onto the substrate carrier prior to coating.
  • Silicone adhesives are typically composed of two main components, a siloxane polymer and a silicate resin. Silicone adhesives are either supplied pre-cross linked, supplied in a hydrocarbon solvent or in a silane solvent. Or as a two-part system where the first part comprises a cross-linking agent and the other part comprises a catalyst that in most cases is an organometallic catalyst, typically an organoplatinum catalyst.
  • Suitable silicones for the present invention may be polydimethylsiloxane, polymetylphenylsiloxane, alkylsiloxane, alkyoxysiloxane.
  • An example of a suitable silicate resin may be trimetylsiloxy silicate, also known as tetrakis silicate.
  • Preferred silicones may be polyorganesiloxane such as polydimethylsiloxane, poly(oxymethylsilylene), poly(oxyethylsilylene) or mixtures thereof, and/or silicones corresponding to general formula shown below: R-[Si(2R)-O-Si(2R)-] where R can generally be a methyl and/or ethyl group or can be substituted by one or several of the following groups -NH2, epoxy, acrylate, metacrylate, acrylamide, ethylene glycol, propylene glycol, halide (Cl, Br, F), maleic anhydride. The degree of substitution can vary from 0 to 90% preferably from 5 to 50% and more preferably from 5 to 20%.
  • the hydrophilic and the hydrophobic silicone may be based on the same silicone elastomer, or they may be based on different silicone elastomers. By using the same type of elastomers the mixing of the two elastomers may be facilitated.
  • the hydrophilic silicones may be silicones sold by Dow Corning under the name BIO-PSA, the series 7-4000 are most preferred.
  • Other silicones such as those known as RTV (room temperature vulcanisable) may also be used when rendered less hydrophobic using the grafting techniques known in the art.
  • the hydrophobic silicone may preferably be RTV silicones, such as those sold by Dow Corning, in a preferred embodiment of the invention the series 7-9000. Other silicones may be suitable.
  • the molecular weight of the silicone elastomers should be in the range of 50,000 to 1,000,000, preferably from 100,000 to 500,000, and more preferably from 50,000 to 250,000.
  • the molecular weight of the hydrophobic and the hydrophilic elastomers may be essentially the same.
  • the molecular weight of the hydrophilic silicone elastomer is considerably smaller than the molecular weight of the hydrophobic silicone elastomer.
  • the adhesive may be in the form of a foam.
  • the foam may be obtained by promptly releasing the pressure of pressurized cured silicone adhesive while it is still hot. Pressurization and nitrogen, and carbon dioxide may also be used to control the structure of the foam. Other blowing agents well known in the art may also be used in order to control the foaming time as well as the foam structure.
  • foaming the adhesive of the present invention a silicone adhesive with a better MVTR (moisture and vapor transmission rate)is achieved ,and furthermore, the adhesive obtains cushioning effect too.
  • MVTR moisture and vapor transmission rate
  • Another way of increasing the MVTR is mixing a fluid into the silicone composition; the fluid has a low boiling point and is not immiscible with silicone. After coating and curing, the immiscible fluid lies within the coating as a micro droplets. The micro droplets of low boiling points fluid are evacuated by vacuum. The resulting adhesive will be in the form of a microporous mass with improved MVTR.
  • composition of the present invention may optionally comprise water absorbent material.
  • the incorporation of absorbent material may increase the absorbency and the MVTR of the adhesive.
  • the initial absorbency of the adhesive of the present invention may be increased by the addition of water absorbent material.
  • the water absorbent material may be in the form of particles or fibers.
  • the water absorbent material is preferably selected from the group of carboxy methyl cellulose (CMC) such as those sold by Hercules under the trade name Aquasorb® or cross-linked polyoxyethelenes, polyoxpropylenes, polyoxy (ethylene-propylene), such as those commercialized by Veramatrix A/S, under the generic name Versabeads ®, or crosslinked polyacrylates, known as super absorbing particles (SAP), such as those sold by Atofina under the trade name Norsocryl®., acrylates, alginates, chitosans, polysaccharides and derivatives or mixtures thereof.
  • CMC carboxy methyl cellulose
  • Aquasorb® cross-linked polyoxyethelenes
  • polyoxpropylenes polyoxy (ethylene-propylene)
  • polyoxy (ethylene-propylene) such as those commercialized by Veramatrix A/S
  • Versabeads ® Versabeads ®
  • SAP super absorbing particles
  • the adhesive of the present invention is especially suitable for adhering to the skin or mucous of a living being, such as a human.
  • the adhesive is skin-friendly, provides a good tack, high flexibility, softness, permeability and is easy to remove.
  • the adhesive may be suitable as a medical adhesive in medical devices, such as wound dressings, ostomy appliances, incontinence devices and other situations where a highly skin-friendly adhesive is desired.
  • the invention further relates to a wound care device comprising an adhesive composition comprising hydrophilic silicone elastomers and hydrophobic silicone elastomers and optionally water absorbent material, wherein the ratio between the hydrophilic silicone elastomers and the hydrophobic silicone elastomers is from 5:95 to 95:5.
  • an ostomy device comprising an adhesive composition comprising hydrophilic silicone elastomers and hydrophobic silicone elastomers and optionally water absorbent material, wherein the ratio between the hydrophilic silicone elastomers and the hydrophobic silicone elastomers is from 5:95 to 95:5.
  • Hydrophilic silicone resin from Dow Corning sold under the trade name BIO-PSA 7-4300.
  • Silicone 7-9800 is a two parts system with a component A comprising a catalyst and a component B comprising a cross-linking agent.
  • BIO-PSA 7-4300 100 parts were dissolved in 40 parts of n-hexane under stirring at room temperature for 20 minutes. 50 parts of silicone 7-9800 (component A and B in a one to one ratio) were added and the mixture was stirred for another 5 minutes, 20 parts of CMC were then added. The mixture was stirred for 3 minutes. From the mixture a 500 microns film was coated on a polyurethane film having 350 microns in thickness. After the n-hexane has evaporated, strips of 10 cm in length and 2 cm in width were cut and peel force test at 180 deg. was performed and an average peel force of 2,5 N was measured. Test of water uptake was also performed and an absorption of 800 gsm. (gram per square meter) after 24 hours was determined.
  • the adhesive was applied on to human skin and showed no cell stripping after removal, compared to a conventional adhesive.
  • Example 2 Same as Example 1, except that CMC was replaced by 20 parts of Norsocryl XFS. n-hexane was replaced by 40 parts of HMDS (hexamethylene disiloxane). A peel force of 1,8 N was determined according to the method described in Example 1, and a water uptake of 3400 gsm. after 24 hours was measured.
  • the adhesive was used for attaching an ostomy device directly to the skin. After removing of the device no traces of skin irritation or cell stripping was noticed.
  • An urine collecting device An urine collecting device
  • Example 2 Same as Example 1 except that more Pt based catalyst was added, by using silicone 7-9800 where component A and B were in a ratio 60:40.. 7.6 N in peel force were obtained when the composition was cured for at least 24 hours at 40 °C, and 7 N when the composition was cured for at least 24 hours at 80 °C.
  • the adhesive was used for attaching a urine collector to male genital organ, the adhesive provided a tight and leakage proof fit and the patient suffered no pain while removing the device.
  • BIO-PSA 7-4300 100 parts was dissolved in 40 parts of n-hexane under stirring at room temperature for 20 minutes. 20 parts of CMC were then added. The mixture was stirred for 3 minutes. From the mixture a 500 microns film was coated on a polyurethane film having 35 microns in thickness. After the n-hexane had evaporated, strips of 10 cm in length and 2 cm in width were cut and peel force was determined at 180 deg. A peel force of 14,8 N was obtained. Water uptake was also measured by immersion in water and an absorption of 1162 gsm per 24 hours (gram per square meter) was found. After 24 hours the adhesive began to decompose due to the lack of cohesiveness of the adhesive.
  • BIO-PSA 7-4300 70 parts was dissolved in 40 parts of n-hexane under stirring at room temperature for 20 minutes, and mixed with 30 parts of silicone 7-9800.
  • silicone 7-9800 90 parts were mixed with 5 parts of silicone 7-4300 dissolved in n-hexane, then 25 part of CMC were added and the mixture was stirred for 3 minutes.
  • the mixture was then coated on a PU film, small beads of 1 mm in diameter of NaCl were spread on the surface of the coating (NaCl beads covered 25% of the total area), When the coating was cured the film was immersed in water for three hours, thus dissolving the beads.
  • the MVTR was increased from 900 gr/m 2 /24h (without NaCl treatment) to 1200 gr/m 2 /24h (after NaCl treatment).
  • silicone 7-9800 90 parts were mixed with 10 parts of silicone 7-4300 dissolved in n-hexane, 25 part of CMC were added and stirred for 3 minutes.
  • the mixture was coated on a PU film, small beads of 1 mm in diameter made of a mixture of citric acid and backing soda were spread on the surface of the coating (the beads covered 25% of the total area.
  • the coating was cured the film was immersed in water for 30 min, and the beads were dissolved.
  • the MVTR was increased from 900 gr/m2/24h to 1500 gr/m 2 /24h.

Landscapes

  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Description

    BACKGROUND OF THE INVENTION 1. Field of the Invention
  • The invention relates to an adhesive composition and a medical device comprising an adhesive composition.
  • 2. Description of the Related Art
  • Medical devices, such as wound care devices and ostomy appliances may comprise adhesives for direct contact with the skin. It is important that the adhesive is skin-friendly, as the skin often is damaged or just extremely fragile, especially when handling chronic wounds. Different suitable adhesives are known in the art. Hydrocolloid adhesives are often used, due to their permeability and good absorption properties. Acrylic adhesives may also be used, especially for thin applications, as the permeability is low.
  • Silicone adhesives are very skin-friendly and very suitable for donating active agents, such as in medicated patches, but they are also rather occlusive and hydrophobic, which is a mayor disadvantage for a product being worn for prolonged period, such as wound dressings, ostomy appliances or incontinence devices.
  • Attempts have been made for preparing a more hydrophilic silicone adhesive. However, these adhesives tend to be difficult to remove due to a higher tack and lower cohesion, and are thus not very useful for application to fragile or damaged skin.
  • Another drawback connected to the use of silicone adhesives is the poor absorption properties. This problem may be solved by incorporating absorbent material e.g. in the form of super absorbent particles.
  • International patent application No. WO 02/087642 discloses an adhesive comprising a hydrophilic phase and a hydrophobic phase. The hydrophobic phase may be a silicone elastomer and the hydrophilic phase may be a water absorbing mixture of hydrophilic polymers of non-silicone origin.
  • In International patent application No. WO 02/076519 is disclosed a silicone-based moisture absorbing matrix for wound care products. The sticky matrix comprises silicone, gelling agent and optionally a silicone resin. Both silicone compounds are hydrophobic and the reference is silent with respect to the use of hydrophilic silicone.
  • EP 0312 265 discloses adhesive compositions comprising blends of polyethylene oxide-grafted silicone polymers with resinous copolymers. The adhesive compositions enhance release, in a controlled fashion, of bioactive or chemical agents blended or otherwise dispersed through the compositions.
  • SUMMARY OF THE INVENTION
  • The object of the present invention is to provide an adhesive composition, being skin-friendly and at the same time having good permeability properties.
  • Another object of the invention is to provide a silicone adhesive with absorption properties.
  • Yet another object of the invention is to provide a skin-friendly adhesive with a good cohesion to the skin and yet easy to remove.
  • Still another object of the invention is to provide a skin-friendly adhesive that reduces cell-stripping when removed from the skin.
  • Still another object of the invention is to provide an adhesive with good cohesion.
  • Detailed Description of the Present Invention
  • The invention relates to an adhesive composition comprising hydrophilic silicone elastomers and hydrophobic silicone elastomers and optionally water absorbent material, wherein the ratio between the hydrophilic silicone elastomers and the hydrophobic silicone elastomers is from 5:95 to 95:5.
  • The ratio between the hydrophilic silicone elastomers and the hydrophobic silicone elastomers may be from 10:90 to 90:10, preferably 20:80 to 80:20, more preferred 30:70 to 70:30 and most preferred 40:60 to 60:40.
  • Preferably, the ratio between the hydrophilic silicone and the hydrophobic silicone is from 10:90 to 40:60, more preferably from 20:80 to 30:70.
  • In one embodiment of the invention the ratio between the hydrophilic silicone and the hydrophobic silicone is from 5:95 to 50:50. In another embodiment of the invention ratio between the hydrophilic silicone and the hydrophobic silicone is from 95:5 to 50:50.
  • The ratio may in one embodiment of the invention be 25:75.
  • In another embodiment of the invention, the ratio between the hydrophilic silicone and the hydrophobic silicone is from 90:10 to 60:40, more preferably from 80:20 to 70:30.
  • In a preferred embodiment of the invention the ratio is 75:25.
  • By mixing hydrophobic silicone and hydrophilic silicone into an adhesive composition the interaction between the two groups of polymers are optimal, due to their related nature, compared to mixtures of hydrophobic silicone and other hydrophilic polymers than silicones.
  • Silicones such as trimethylsilyloxane terminated polydimetylsiloxane, are hydrophobic. These have an advantage of being inert to hydrophilic substances, which means that these substances are not dissolved in silicone and therefore are able to migrate out of the silicone. This explains why silicone is a good as drug release matrix.
  • For the purpose of this invention we need a silicone that is relatively less hydrophobic than trimethylsilyloxy-terminated polydimetylsiloxane but still can be used as a PSA (pressure sensitive adhesive) adhesive.
  • Hydrophobic silicones can be made hydrophilic by replacing some of the methyl groups along the chain or the chain ends with hydrophilic moieties well-known to those skilled in the art, such moieties may be oxymethylene and/or oxypropylene, acrylate amide, amines imines etc. The hydrophilicity or hydrophobicity may also be adjusted to the desired value by radio frequency or electrical current phase plasma treatment or corona treatment of the silicone fluid stream that passes into a chamber where plasma or corona is generated., and that or these monomer moieties that renders hydrophobic silicone hydrophilic is/are introduced.
  • Hydrophilic silicones capable of absorbing small amounts of water are known. An example may be Silicone 4000 series produced by DOW Corning. The water absorption may be further increased by incorporating water-absorbing material such as CMC or cross-linked acrylates. However, such silicone adhesive has low cohesiveness and is thus unsuitable in use for medical devices.
  • It has surprisingly been shown that the cohesiveness of the silicone adhesive may be increased by combining hydrophobic and hydrophilic silicone.
  • As a measure of the right combination of the amount of hydrophobic and hydrophilic silicone providing an adhesive composition with an optimal total hydrophilicity the surface energy can be used. The surface energy of the composition according to the present invention, measured in terms of water-in-air contact angle for a fully cured silicone mixture against a glass plate, without the absorbing agent and other ingredients mentioned in examples below, is preferably between 65 and 105 degree, more preferred between 75 and 100 degree and most preferred between 80 and 95 degree.
  • The surface energy can be measured by the water-in-air contact angle method known in the art, where the angle between a drop of distilled water and the surface of the substrate is measured.
  • To supplement contact angle findings, surface energy is also determined from the chemical structure of the silicone mixtures using the surface and interfacial tension of polymers, oligomers, plasticizers, and additives involved in the composition. These data are available in polymer handbooks.
  • The cohesiveness of the adhesive of the present invention is important when the adhesive has to be removed from a skin or wound site. Low cohesiveness may result in adhesive residues left on the skin or wound site or in the areas surrounding the wound site, and/or trauma while removing the adhesive due to a high peel force.
  • The ratio that suits both water absorption and gel cohesiveness may also influence the peel force of the PSA to be achieved.
  • The actual peel span of silicone elastomers lies between over 70 N for a 100% hydrophilic elastomer to around 0,5 N for 100% hydrophobic elastomer.
  • The peel force of the adhesive of the present invention may be from 1 N to 20 N measured according to 180 degree method DS/EN/28510-2.
  • In order for an adhesive composition to be suitable for medical use it is preferred that the peel force between 1 N and 10 N, more preferably the peel force is from 1 N to 5 N.
  • Peel force and gel cohesiveness can be influenced by varying the ratio between the hydrophilic and the hydrophobic silicone. Furthermore, the peel force may be further adjusted by incorporating some other ingredients such as kaolin, crystalline silica magnesium oxide, calcium carbonate or other reinforcing fillers, plasticisers, such as a low molecular silicone oil, e.g. hexamethylene disiloxane, soya bean oil or the derivative thereof, castor oil or the derivative thereof, or other additives known to persons skilled in the art.
  • Examples of additives may be UV stabilizers such as those known under trade name "Irganox, Cyanox, Hostanox", antioxidants, and cross-linking agents such as peroxides, divinylbenzene. Other suitable compounds may be acrylic or vinyl ended silicone moieties having an average molecular weight ranging 100 to 10.000. These moieties are also referred to as cross-linking agents. Adhesion promoters may also be added to the silicone mixtures in order to improve the affinity of the silicone adhesive for the substrate onto which the adhesive is to be applied. The adhesion promoters may be silicone based, such as those commercialized by Dow Corning under the name "Silane Z-603". Titan based such those commercialized by Du Pont under the name "Tyzor AA 105" may also be used. Adhesion promoters can be mixed into the silicone composition prior to coating and curing, or simply used as a primer onto the substrate carrier prior to coating.
  • Silicone adhesives are typically composed of two main components, a siloxane polymer and a silicate resin. Silicone adhesives are either supplied pre-cross linked, supplied in a hydrocarbon solvent or in a silane solvent. Or as a two-part system where the first part comprises a cross-linking agent and the other part comprises a catalyst that in most cases is an organometallic catalyst, typically an organoplatinum catalyst.
  • Examples of suitable silicones for the present invention may be polydimethylsiloxane, polymetylphenylsiloxane, alkylsiloxane, alkyoxysiloxane. An example of a suitable silicate resin may be trimetylsiloxy silicate, also known as tetrakis silicate.
  • Preferred silicones may be polyorganesiloxane such as polydimethylsiloxane, poly(oxymethylsilylene), poly(oxyethylsilylene) or mixtures thereof, and/or silicones corresponding to general formula shown below:

            R-[Si(2R)-O-Si(2R)-]

    where R can generally be a methyl and/or ethyl group or can be substituted by one or several of the following groups -NH2, epoxy, acrylate, metacrylate, acrylamide, ethylene glycol, propylene glycol, halide (Cl, Br, F), maleic anhydride. The degree of substitution can vary from 0 to 90% preferably from 5 to 50% and more preferably from 5 to 20%.
  • The hydrophilic and the hydrophobic silicone may be based on the same silicone elastomer, or they may be based on different silicone elastomers. By using the same type of elastomers the mixing of the two elastomers may be facilitated.
  • In one embodiment of the invention the hydrophilic silicones may be silicones sold by Dow Corning under the name BIO-PSA, the series 7-4000 are most preferred. Other silicones such as those known as RTV (room temperature vulcanisable) may also be used when rendered less hydrophobic using the grafting techniques known in the art.
  • The hydrophobic silicone may preferably be RTV silicones, such as those sold by Dow Corning, in a preferred embodiment of the invention the series 7-9000. Other silicones may be suitable.
  • The molecular weight of the silicone elastomers should be in the range of 50,000 to 1,000,000, preferably from 100,000 to 500,000, and more preferably from 50,000 to 250,000. The molecular weight of the hydrophobic and the hydrophilic elastomers may be essentially the same.
  • In one embodiment the molecular weight of the hydrophilic silicone elastomer is considerably smaller than the molecular weight of the hydrophobic silicone elastomer.
  • In a further embodiment of the invention the adhesive may be in the form of a foam.
  • The foam may be obtained by promptly releasing the pressure of pressurized cured silicone adhesive while it is still hot. Pressurization and nitrogen, and carbon dioxide may also be used to control the structure of the foam. Other blowing agents well known in the art may also be used in order to control the foaming time as well as the foam structure. By foaming the adhesive of the present invention a silicone adhesive with a better MVTR (moisture and vapor transmission rate)is achieved ,and furthermore, the adhesive obtains cushioning effect too. These two characteristics may also be obtained by mixing watersoluble particles into the silicone composition, after curing of the adhesive; these particles are leached in the water, leaving small craters, through which a better MVTR may be obtained. Another way of increasing the MVTR is mixing a fluid into the silicone composition; the fluid has a low boiling point and is not immiscible with silicone. After coating and curing, the immiscible fluid lies within the coating as a micro droplets. The micro droplets of low boiling points fluid are evacuated by vacuum. The resulting adhesive will be in the form of a microporous mass with improved MVTR.
  • The composition of the present invention may optionally comprise water absorbent material. The incorporation of absorbent material may increase the absorbency and the MVTR of the adhesive.
  • The initial absorbency of the adhesive of the present invention may be increased by the addition of water absorbent material.
  • The water absorbent material may be in the form of particles or fibers.
  • The water absorbent material is preferably selected from the group of carboxy methyl cellulose (CMC) such as those sold by Hercules under the trade name Aquasorb® or cross-linked polyoxyethelenes, polyoxpropylenes, polyoxy (ethylene-propylene), such as those commercialized by Veramatrix A/S, under the generic name Versabeads ®, or crosslinked polyacrylates, known as super absorbing particles (SAP), such as those sold by Atofina under the trade name Norsocryl®., acrylates, alginates, chitosans, polysaccharides and derivatives or mixtures thereof.
  • The adhesive of the present invention is especially suitable for adhering to the skin or mucous of a living being, such as a human. The adhesive is skin-friendly, provides a good tack, high flexibility, softness, permeability and is easy to remove. The adhesive may be suitable as a medical adhesive in medical devices, such as wound dressings, ostomy appliances, incontinence devices and other situations where a highly skin-friendly adhesive is desired.
  • The invention further relates to a wound care device comprising an adhesive composition comprising hydrophilic silicone elastomers and hydrophobic silicone elastomers and optionally water absorbent material, wherein the ratio between the hydrophilic silicone elastomers and the hydrophobic silicone elastomers is from 5:95 to 95:5.
  • Still further, the invention relates to an ostomy device comprising an adhesive composition comprising hydrophilic silicone elastomers and hydrophobic silicone elastomers and optionally water absorbent material, wherein the ratio between the hydrophilic silicone elastomers and the hydrophobic silicone elastomers is from 5:95 to 95:5.
  • MATERIALS AND METHODS
  • Hydrophilic silicone resin from Dow Corning sold under the trade name BIO-PSA 7-4300.
  • Hydrophobic silicone resin from Dow Corning sold under the trade name silicone 7-9800. Silicone 7-9800 is a two parts system with a component A comprising a catalyst and a component B comprising a cross-linking agent.
  • CMC
  • Acrylate polymer from Atofina sold under the trade name Norsocryl XFS.
    Versa-beads-O from Versamatrix
    Versa-beads-A from Versamatrix
    Versa-beads-E from Versamatrix
    N-hexane
    Hexamethyldisiloxane
  • EXAMPLE 1 Preparation of adhesive
  • 100 parts of BIO-PSA 7-4300 were dissolved in 40 parts of n-hexane under stirring at room temperature for 20 minutes. 50 parts of silicone 7-9800 (component A and B in a one to one ratio) were added and the mixture was stirred for another 5 minutes, 20 parts of CMC were then added. The mixture was stirred for 3 minutes. From the mixture a 500 microns film was coated on a polyurethane film having 350 microns in thickness. After the n-hexane has evaporated, strips of 10 cm in length and 2 cm in width were cut and peel force test at 180 deg. was performed and an average peel force of 2,5 N was measured. Test of water uptake was also performed and an absorption of 800 gsm. (gram per square meter) after 24 hours was determined.
  • The adhesive was applied on to human skin and showed no cell stripping after removal, compared to a conventional adhesive.
  • EXAMPLE 2 An ostomy device
  • Same as Example 1, except that CMC was replaced by 20 parts of Norsocryl XFS. n-hexane was replaced by 40 parts of HMDS (hexamethylene disiloxane). A peel force of 1,8 N was determined according to the method described in Example 1, and a water uptake of 3400 gsm. after 24 hours was measured.
  • The adhesive was used for attaching an ostomy device directly to the skin. After removing of the device no traces of skin irritation or cell stripping was noticed.
  • EXAMPLE 3 An urine collecting device
  • Same as Example 1 except that more Pt based catalyst was added, by using silicone 7-9800 where component A and B were in a ratio 60:40.. 7.6 N in peel force were obtained when the composition was cured for at least 24 hours at 40 °C, and 7 N when the composition was cured for at least 24 hours at 80 °C.
  • The adhesive was used for attaching a urine collector to male genital organ, the adhesive provided a tight and leakage proof fit and the patient suffered no pain while removing the device.
  • EXAMPLE 4 (comparative) Hydrophilic silicone adhesive with CMC
  • 100 parts of BIO-PSA 7-4300 was dissolved in 40 parts of n-hexane under stirring at room temperature for 20 minutes. 20 parts of CMC were then added. The mixture was stirred for 3 minutes. From the mixture a 500 microns film was coated on a polyurethane film having 35 microns in thickness. After the n-hexane had evaporated, strips of 10 cm in length and 2 cm in width were cut and peel force was determined at 180 deg. A peel force of 14,8 N was obtained. Water uptake was also measured by immersion in water and an absorption of 1162 gsm per 24 hours (gram per square meter) was found. After 24 hours the adhesive began to decompose due to the lack of cohesiveness of the adhesive.
  • EXAMPLE 5 Hydrophilic/hydrophobic silicone with CMC
  • 70 parts of BIO-PSA 7-4300 was dissolved in 40 parts of n-hexane under stirring at room temperature for 20 minutes, and mixed with 30 parts of silicone 7-9800.
  • 20 parts of CMC were then added. The mixture was stirred for 3 minutes. From the mixture a 500 microns film was coated on a polyurethane film having 35 microns in thickness. After the n-hexane had evaporated, strips of 10 cm in length and 2 cm in width were cut and peel force was determined at 180 deg. A peel force of 12,0 N was obtained. Water uptake was also measured by immersion in water and an absorption of 1062 gsm per 24 hours (gram per square meter) was found. After 24 hours the adhesive was still cohesive and did not dissolve or disintegrate in the water.
  • EXAMPLE 6 Adhesive with improved MVTR prepared by use of NaCl
  • 90 parts of silicone 7-9800 were mixed with 5 parts of silicone 7-4300 dissolved in n-hexane, then 25 part of CMC were added and the mixture was stirred for 3 minutes. The mixture was then coated on a PU film, small beads of 1 mm in diameter of NaCl were spread on the surface of the coating (NaCl beads covered 25% of the total area), When the coating was cured the film was immersed in water for three hours, thus dissolving the beads. The MVTR was increased from 900 gr/m2/24h (without NaCl treatment) to 1200 gr/m2/24h (after NaCl treatment).
  • EXAMPLE 7 Adhesive with improved MVTR prepared by use of blowing agent
  • 90 parts of silicone 7-9800 were mixed with 10 parts of silicone 7-4300 dissolved in n-hexane, 25 part of CMC were added and stirred for 3 minutes. The mixture was coated on a PU film, small beads of 1 mm in diameter made of a mixture of citric acid and backing soda were spread on the surface of the coating (the beads covered 25% of the total area. When the coating was cured the film was immersed in water for 30 min, and the beads were dissolved. The MVTR was increased from 900 gr/m2/24h to 1500 gr/m2/24h.
  • EXAMPLE 8 Adhesive with improved MVTR prepared by using PEG
  • 95 parts of silicone 7-9800 and 5 parts of silicone 7-4300 dissolved in n-hexane were mixed with 25 part of CMC, and 25 parts of polyethylene glycol 600 were added and gently stirred to favor the formation of microdroplets, after 3 minutes of stirring. The mixture was coated on a PU film, and cured. When the coating was cured the film was exposed to vacuum for 30 min. The MVTR was increased from 900 gr/m2/24h to 1100 gr/m2/24h.

Claims (12)

  1. An adhesive composition comprising hydrophilic silicone elastomers and hydrophobic silicone elastomers in a ratio between the hydrophilic silicone elastomers and the hydrophobic silicone elastomers from 5:95 to 95:5 and further comprising water absorbent material, the water absorbent material either selected from the group of CMC, acrylates, alginates, chitosans, polysaccharides or mixtures thereof, and/or the water absorbent material is in the form of particles.
  2. An adhesive composition according to claim 1 wherein the water-in-air contact angle is between 65 and 105 degree.
  3. An adhesive composition according to claim 1 or 2, wherein the peel force is from 1 to 20 N.
  4. An adhesive composition according to any of claims 1-3 wherein the hydrophilic silicone elastomer is polyorganosiloxane elastomers.
  5. An adhesive composition according to any of claims 1-4 wherein the hydrophobic silicone elastomer is polyorganosiloxane elastomers.
  6. An adhesive composition according to any of claims 1-5 wherein the hydrophilic and the hydrophobic silicone are based on the same silicone elastomer.
  7. An adhesive composition according to any of claims 1-6 wherein the molecular weight of the silicone elastomers is between 50,000 and 1,000,000.
  8. An adhesive composition according to any of claims 1-7 wherein the water absorbent material is in the form of particles.
  9. An adhesive composition according to any of claims 1-8 wherein the water absorbent material is selected from the group of CMC, acrylates, alginates, chitosans, polysaccharides or mixtures thereof.
  10. A wound care device comprising an adhesive according to any of claims 1-9.
  11. An ostomy device comprising an adhesive according to any of claims 1-9.
  12. An incontinence device comprising an adhesive according to any of claims 1-9.
EP04762804.5A 2003-09-02 2004-09-02 Adhesive composition comprising hydrophilic and hydrophobic silicone elastomers Expired - Lifetime EP1713523B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301256 2003-09-02
DKPA200301871 2003-12-17
PCT/DK2004/000584 WO2005021058A2 (en) 2003-09-02 2004-09-02 Adhesive composition comprising hydrophilic and hydrophobic silicone elastomers

Publications (2)

Publication Number Publication Date
EP1713523A2 EP1713523A2 (en) 2006-10-25
EP1713523B1 true EP1713523B1 (en) 2015-07-01

Family

ID=34276703

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04762804.5A Expired - Lifetime EP1713523B1 (en) 2003-09-02 2004-09-02 Adhesive composition comprising hydrophilic and hydrophobic silicone elastomers

Country Status (3)

Country Link
US (3) US7842752B2 (en)
EP (1) EP1713523B1 (en)
WO (1) WO2005021058A2 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606661D0 (en) 2006-04-03 2006-05-10 Brightwake Ltd Improvements relating to dressings
RU2008147888A (en) * 2006-05-05 2010-06-10 Колопласт А/С (Dk) COMPOSITION OF ADHESIVE SENSITIVE FOR PRESSURE CONTAINING A crosslinked POLYALKYLENEXIDE AND HYDROPHYLENE HYDROPHILIC AGENTS
US9348167B2 (en) * 2007-03-19 2016-05-24 Via Optronics Gmbh Enhanced liquid crystal display system and methods
TWI444942B (en) * 2007-04-20 2014-07-11 Via Optronics Gmbh Bezelless display system and method for construction thereof
TW200912720A (en) * 2007-04-24 2009-03-16 White Electronics Designs Corp Interactive display system
JP2010531161A (en) 2007-06-19 2010-09-24 コロプラスト アクティーゼルスカブ Multilayer adhesive orthosis
ATE490749T1 (en) * 2007-06-25 2010-12-15 Coloplast As STOMARY DEVICE WITH MULTIPLE PEEL FOILS
EP2305187A3 (en) 2007-07-06 2014-05-28 Coloplast A/S A collecting device for body fluids
US20110137243A1 (en) * 2007-09-06 2011-06-09 Abbott Cardiovascular Systems Inc. Coating On A Balloon Device
JP2011528243A (en) 2008-07-18 2011-11-17 コロプラスト アクティーゼルスカブ Body excreta collection equipment including layered adhesive structure
WO2010066254A1 (en) 2008-12-08 2010-06-17 Coloplast A/S A body waste collecting device comprising a layered adhesive construction with a film layer
US9486553B2 (en) 2009-07-16 2016-11-08 Brightwake Limited Method
US9295663B2 (en) 2010-07-14 2016-03-29 Abbott Cardiovascular Systems Inc. Drug coated balloon with in-situ formed drug containing microspheres
EP2744868A1 (en) * 2011-08-17 2014-06-25 3M Innovative Properties Company A hydrophobic adhesive with absorbent fibers
GB2493960B (en) 2011-08-25 2013-09-18 Brightwake Ltd Non-adherent wound dressing
CN104870567B (en) 2012-10-22 2018-09-07 艾利丹尼森公司 It is dispersed in the hybrid material of the crosslinked micro-gel particles in adhesive
JP6053951B2 (en) 2012-12-07 2016-12-27 スリーエム イノベイティブ プロパティズ カンパニー Silicone gel adhesive with hydrophilic and antibacterial properties
CN106456828A (en) * 2014-05-23 2017-02-22 3M创新有限公司 A discontinuous silicone adhesive article
JP6822949B2 (en) * 2014-10-09 2021-01-27 コロプラスト アクティーゼルスカブ A composition comprising a polymer and a switching initiator
AU2016211382B2 (en) * 2015-01-28 2019-10-10 Hollister Incorporated Adhesive for moist tissue and peristomal device made using the same
GB201520461D0 (en) * 2015-11-20 2016-01-06 Dow Corning Water pick up sealant
US11512237B2 (en) 2015-11-20 2022-11-29 Dow Silicones Corporation Room temperature curable compositions
FI3429644T3 (en) * 2016-03-14 2023-03-14 Trio Healthcare Ltd Skin compatible adhesive composition
EP3515960B1 (en) 2016-09-19 2022-06-01 Dow Silicones Corporation Personal care compositions including a polyurethane-polyorganosiloxane copolymer
WO2018052645A1 (en) 2016-09-19 2018-03-22 Dow Corning Corporation Skin contact adhesive and methods for its preparation and use
JP6816264B2 (en) 2016-09-19 2021-01-20 ダウ シリコーンズ コーポレーション Polyurethane-polyorganosiloxane copolymer and its preparation method
EP3727597A1 (en) 2017-12-21 2020-10-28 Dow Silicones Corporation Cosmetic composition comprising silicone materials
EP3728539A1 (en) 2017-12-21 2020-10-28 Dow Silicones Corporation Fabric-care composition comprising silicone materials
JP2021101750A (en) * 2018-03-30 2021-07-15 テルモ株式会社 Medical tool
CN112316216A (en) * 2018-10-31 2021-02-05 湖南博隽生物医药有限公司 Material for nephrostomy tube with high biological safety
GB201904400D0 (en) 2019-03-29 2019-05-15 Trio Healthcare Ltd Screen printing apparatus and method
GB201904403D0 (en) 2019-03-29 2019-05-15 Trio Healthcare Ltd Skin compatible silicone composition
GB201904402D0 (en) 2019-03-29 2019-05-15 Trio Healthcare Ltd Foamed skin compatible silicone composition
US11320570B2 (en) * 2020-04-08 2022-05-03 Delta Electronics, Inc. Wavelength converting device
DE112021004258T5 (en) * 2020-08-13 2023-06-15 R.D. Abbott Company, Inc. METHOD OF MAKING A COMPOSITE MATRIX USING INCORPORATION OF CARBON NANOTUBE
CN115491168A (en) * 2022-08-22 2022-12-20 振德医疗用品股份有限公司 Ultramicro porous organic silicon gel and preparation method thereof
EP4394009A1 (en) 2022-12-27 2024-07-03 Advanced Silicone Coating Silicone layer having absorbent and desorbent properties

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63502986A (en) * 1985-12-12 1988-11-02 フレックスコン・カンパニ−・インコ−ポレ−テッド Transdermal methods and adhesives
US4898920A (en) * 1987-10-15 1990-02-06 Dow Corning Corporation Adhesive compositions, controlled release compositions and transdermal delivery device
JP2849937B2 (en) * 1990-04-18 1999-01-27 日東電工株式会社 Medical patch
US5473026A (en) * 1994-06-20 1995-12-05 Dow Corning Corporation Moisture-curable hot melt silicone pressure-sensitive adhesives
SE9801899L (en) * 1998-05-28 1999-07-05 Moelnlycke Health Care Ab Wound dressing or skin fixing tape comprising a plastic film laminate and an irregular surface structure material coated with a sticky elastomer
DE10114382A1 (en) * 2001-03-23 2002-09-26 Beiersdorf Ag Moisture-absorbing material used for plasters, medical fixings, wound coverings and bandages comprises adhesive matrix of silicon, gel former and optionally silicone resin
DE60239528D1 (en) 2001-05-01 2011-05-05 Corium International Redwood City TWO-PHASE, WATER-ABSORBING BIOADHESIVE COMPOSITION

Also Published As

Publication number Publication date
EP1713523A2 (en) 2006-10-25
WO2005021058A2 (en) 2005-03-10
US20120149810A1 (en) 2012-06-14
US20070020319A1 (en) 2007-01-25
WO2005021058A3 (en) 2005-06-09
US8741990B2 (en) 2014-06-03
US20110034847A1 (en) 2011-02-10
US8124675B2 (en) 2012-02-28
US7842752B2 (en) 2010-11-30

Similar Documents

Publication Publication Date Title
EP1713523B1 (en) Adhesive composition comprising hydrophilic and hydrophobic silicone elastomers
EP2018161B1 (en) A pressure sensitive adhesive composition comprising cross-linked polyalkylene oxide and water absorbent hydrophilic agents
JP4551073B2 (en) Adhesive sheet for skin application
CA2766116C (en) Pressure sensitive silicone adhesives with amphiphilic copolymers
US11534523B2 (en) Silicone absorbent adhesive layer
CA2949944A1 (en) A discontinuous silicone adhesive article
MX2007001417A (en) Hot-melt silicone based ostomy and wound care skin attachment adhesives.
JP2012532959A5 (en)
CN102065801B (en) An ostomy collecting device
JP6557881B2 (en) Skin adhesive and patch and method for producing skin adhesive
EP3104903A1 (en) Silicone adhesives to secure medical appliances to mammalian body
CN115666666A (en) Novel antimicrobial topical skin closure compositions and systems
EP2745851A1 (en) Silicone film
JP2015501346A (en) High viscosity silicone adhesive
EP2314287A1 (en) Pressure-sensitive adhesive sheet to be stuck to the skin
WO2021124200A1 (en) Adhesive primers and articles including the same
EP4394009A1 (en) Silicone layer having absorbent and desorbent properties
JP2009233316A (en) Pressure-sensitive adhesive composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060403

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20070515

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20141223

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 733543

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150715

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602004047443

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 733543

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150701

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20150701

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151002

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151102

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602004047443

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150902

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

26N No opposition filed

Effective date: 20160404

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150930

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150902

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20040902

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150701

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230927

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230925

Year of fee payment: 20

Ref country code: DE

Payment date: 20230927

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 602004047443

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20240901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20240901